Within PMI-CPMAI–aligned responsible AI practices, deploying AI in healthcare diagnostics requires explicit attention todata privacy, regulatory compliance, and ethical impact on patients. APrivacy Impact Assessment (PIA)is a structured method used to systematically identify, analyze, and mitigate privacy and ethical risks associated with data processing and automated decisions. For an operationalized diagnostic AI tool, a PIA helps the project manager map data flows (collection, storage, use, and sharing), determine the legal basis for processing sensitive health data, highlight potential harms (misuse, breaches, inappropriate access), and define safeguards such as minimization, anonymization, consent handling, and access controls.
PMI-CP–consistent AI governance emphasizes documenting how data is used and how decisions affect individuals, as well as demonstrating that privacy and ethical considerations have been proactively assessed before and during operation. While internal frameworks or protocols (such as generic monitoring or controls) may help manage performance and operations, they do not replace a formal, focused assessment of privacy risk and ethical implications. A PIA provides concrete evidence that the organization hasanticipated the effect of the AI system on patient rights, confidentiality, and trust, making it the most suitable action in this context. Therefore, the project manager shoulddevelop a detailed privacy impact assessment (PIA).
